Evaluation of antidiabetic antihyperlipidemic and pancreatic regeneration, potential of aerial parts of Clitoria ternatea
AUTOR(ES)
Verma, Prashant R., Itankar, Prakash R., Arora, Sumit K.
FONTE
Rev. bras. farmacogn.
DATA DE PUBLICAÇÃO
2013-10
RESUMO
The aim of the present study was to investigate the pancreatic regeneration potential of of diferent fractions of the ethanol extract Clitoria ternateaL., Fabaceae. The antidiabetic and antihyperlipidemic potential was evaluated in streptozotocin-induced diabetic rats and correlated with its in vivoand in vitro antioxidant activity. The extract and its fractions were initially screened for acute and sub-chronic antidiabetic activity in the dose range of 100200 mg/kg. The most potent extract and fractions were further evaluated for pancreatic β-cells regeneration activity along with antioxidant and antihyperlipidemic activity. The polyphenolic, flavonoid and flavanone contents were assessed and correlated with its antidiabetic activity. The most significant pancreatic regeneration activity, antidiabetic and antihyperlipidemic activity and was shown by ethanol extract and butanol soluble fraction at a dose level of 200 mg/kg, while rutin was found to be least potent. In conclusion, pancreatic regeneration studies of ethanol extract treated rats show nesidioblastosis. It is also suggested that the factors causing regeneration are present within the pancreas. The newly generated islets may have formed from the ductal precursor cells and reduced oxidative stress helps in restoration of β-cell function.
Documentos Relacionados
- Antidiabetic and antihyperlipidemic effects of Dillenia indica (L.) leaves extract
- Feno de cunhã (Clitoria ternatea L.) para acabamento de cordeiros
- Formation, regeneration, and transfection of Lactobacillus plantarum protoplasts.
- Evaluation of antidiabetic, antihyperlipidemic and antioxidant effects of Boehmeria nivea (L.) Gaudich., Urticaceae, root extract in streptozotocin-induced diabetic rats
- Growth, regeneration, and tumorigenesis of the prostate activates the PSCA promoter